Jan 15, 2020 / 01:00AM GMT
Richard Vosser - JP Morgan Chase & Co, Research Division - Senior Analyst
Welcome to the Roche presentation at the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to introduce from Roche, Bill Anderson, the CEO of Roche Pharmaceuticals.
Before I hand over to Bill, I'd just point out that the breakout session after his presentation is in the Borgia Room, which is at the back of the hall. Bill, welcome.
William N. Anderson - Roche Holding AG - CEO of Roche Pharmaceuticals
Thanks, Richard. Welcome, everyone. Thanks for being here. I have the duty now to tell you everything that's going on in Roche in 25 minutes. I won't try that.
I do want to -- I want to focus really on 3 themes, really, one is the strategy, which I think everyone is interested in and how we pull this all together, the many diverse parts of what Roche brings in pharmaceuticals, in diagnostics and in the insights businesses. But also I'm going to talk a little bit about culture and the cultural
Roche Holding AG, Bristol-Myers Squibb Co and PhRMA at JPMorgan Healthcare Conference - Panel Session Transcript
Jan 15, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers